Correlation Between INmune Bio and Coya Therapeutics,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both INmune Bio and Coya Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining INmune Bio and Coya Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between INmune Bio and Coya Therapeutics, Common, you can compare the effects of market volatilities on INmune Bio and Coya Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in INmune Bio with a short position of Coya Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of INmune Bio and Coya Therapeutics,.

Diversification Opportunities for INmune Bio and Coya Therapeutics,

0.43
  Correlation Coefficient

Very weak diversification

The 3 months correlation between INmune and Coya is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding INmune Bio and Coya Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Coya Therapeutics, Common and INmune Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on INmune Bio are associated (or correlated) with Coya Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Coya Therapeutics, Common has no effect on the direction of INmune Bio i.e., INmune Bio and Coya Therapeutics, go up and down completely randomly.

Pair Corralation between INmune Bio and Coya Therapeutics,

Given the investment horizon of 90 days INmune Bio is expected to under-perform the Coya Therapeutics,. In addition to that, INmune Bio is 1.26 times more volatile than Coya Therapeutics, Common. It trades about -0.18 of its total potential returns per unit of risk. Coya Therapeutics, Common is currently generating about -0.08 per unit of volatility. If you would invest  635.00  in Coya Therapeutics, Common on October 1, 2024 and sell it today you would lose (43.00) from holding Coya Therapeutics, Common or give up 6.77% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

INmune Bio  vs.  Coya Therapeutics, Common

 Performance 
       Timeline  
INmune Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days INmune Bio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's primary indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Coya Therapeutics, Common 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Coya Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Coya Therapeutics, is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

INmune Bio and Coya Therapeutics, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with INmune Bio and Coya Therapeutics,

The main advantage of trading using opposite INmune Bio and Coya Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if INmune Bio position performs unexpectedly, Coya Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coya Therapeutics, will offset losses from the drop in Coya Therapeutics,'s long position.
The idea behind INmune Bio and Coya Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities